|
ADNP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.86520021649983E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.68059999752879E-08 |
| Normal-vs-Stage2 |
1.9145299999912E-05 |
| Normal-vs-Stage3 |
8.15099987505619E-10 |
| Normal-vs-Stage4 |
6.45789999254021E-09 |
| Stage1-vs-Stage2 |
8.389000E-01 |
| Stage1-vs-Stage3 |
1.365390E-01 |
| Stage1-vs-Stage4 |
1.094000E-01 |
| Stage2-vs-Stage3 |
4.030800E-01 |
| Stage2-vs-Stage4 |
3.580400E-01 |
| Stage3-vs-Stage4 |
8.687600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.19269968638037E-10 |
| Normal-vs-AfricanAmerican |
5.402900E-03 |
| Normal-vs-Asian |
3.84319999999772E-05 |
| Caucasian-vs-AfricanAmerican |
2.960800E-01 |
| Caucasian-vs-Asian |
5.191800E-01 |
| AfricanAmerican-vs-Asian |
6.196200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.84309994938548E-09 |
| Normal-vs-Female |
1.22349996800608E-09 |
| Male-vs-Female |
6.669400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.5845000000958E-07 |
| Normal-vs-Age(41-60Yrs) |
3.07329994786443E-09 |
| Normal-vs-Age(61-80Yrs) |
4.40920000510658E-09 |
| Normal-vs-Age(81-100Yrs) |
2.478600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.633000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.797600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.040000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.582400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.029800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.726000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.038400E-02 |
| Classical-VS-Follicular |
5.036100E-04 |
| Classical-VS-Other |
3.524800E-01 |
| Classical-VS-Normal |
1.8715000005276E-07 |
| Tall-VS-Follicular |
8.199600E-01 |
| Tall-VS-Other |
9.043400E-01 |
| Tall-VS-Normal |
4.28270000019104E-07 |
| Follicular-VS-Other |
8.218600E-01 |
| Follicular-VS-Normal |
4.15469991743578E-10 |
| Other-VS-Normal |
7.821600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.14819972710734E-10 |
| Normal-vs-N1 |
7.96790000645586E-09 |
| N0-vs-N1 |
3.919400E-01 |
|
|
